KYKOF (Kyowa Kirin Co) Retained Earnings : $2,287 Mil (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Kyowa Kirin Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Kyowa Kirin Co's retained earnings for the quarter that ended in Jun. 2024 was $2,287 Mil.

Kyowa Kirin Co's quarterly retained earnings declined from Dec. 2023 ($2,353 Mil) to Mar. 2024 ($2,256 Mil) but then increased from Mar. 2024 ($2,256 Mil) to Jun. 2024 ($2,287 Mil).

Kyowa Kirin Co's annual retained earnings declined from Dec. 2021 ($2,245 Mil) to Dec. 2022 ($2,119 Mil) but then increased from Dec. 2022 ($2,119 Mil) to Dec. 2023 ($2,353 Mil).

Kyowa Kirin Co Retained Earnings Historical Data

The historical data trend for Kyowa Kirin Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co Retained Earnings Chart

Kyowa Kirin Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Retained Earnings

Get a 7-Day Free Trial

1,844.65

2,183.52

2,244.76

2,118.69

2,352.83

Kyowa Kirin Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Retained Earnings	Get a 7-Day Free Trial															2,100.52	2,352.83	2,255.61	2,287.32	-

Kyowa Kirin Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Kyowa Kirin Co (OTCPK:KYKOF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Kyowa Kirin Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (OTCPK:KYKOF) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

KYKOY:USA 4151:Japan KY4:Germany

Address

1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004

Website

http://www.kyowa-kirin.com

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.